Results 201 to 210 of about 7,183 (232)
Some of the next articles are maybe not open access.
Hospital Pharmacy, 2000
Each month, subscribers to The Formulary® Monograph Service receive five to six researched monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada +2 more
openaire +1 more source
Each month, subscribers to The Formulary® Monograph Service receive five to six researched monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada +2 more
openaire +1 more source
Clinical Therapeutics, 2001
Certain shortcomings of the available thrombolytic agents have prompted the search for a more fibrin specific fibrinolytic agent with a longer half-life. Such properties would allow bolus administration, possibly leading to faster reperfusion of occluded arteries.This article focuses on the new thrombolytic agent tenecteplase, reviewing its mechanism ...
L, Davydov, J W, Cheng
openaire +2 more sources
Certain shortcomings of the available thrombolytic agents have prompted the search for a more fibrin specific fibrinolytic agent with a longer half-life. Such properties would allow bolus administration, possibly leading to faster reperfusion of occluded arteries.This article focuses on the new thrombolytic agent tenecteplase, reviewing its mechanism ...
L, Davydov, J W, Cheng
openaire +2 more sources
Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions
Stroke, 2021Aristeidis H Katsanos +2 more
exaly
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke
Stroke, 2021Cathy Zhong +2 more
exaly